{
}
UBS AG has maintained a "Buy" rating for Merck KGaA, setting a target price of €190 following the Group's Capital Markets Day. The stock rose by 5.7% to €162.95, indicating a potential upside of 16.6%. Since the start of 2024, Merck's share price has increased by 14.7%, with Q3 2024 results expected on November 14.
UBS AG has maintained a "Neutral" rating on Sartorius vz shares, setting a target price of 264 euros following the third-quarter results. While consolidated sales fell short of expectations, the operating result met forecasts, and a recovery in the BPS division may positively influence the market. Sartorius vz shares rose 13.9% in XETRA trading, though they have declined 21.7% since the start of 2024.
UBS has maintained a 'Neutral' rating for Sartorius with a target price of 264 euros following the third-quarter results. While the laboratory services provider's consolidated sales fell short of consensus estimates, its operating profit met expectations. The recovery in orders within the BPS division may positively influence the market.
UBS has maintained a 'Neutral' rating for Sartorius with a target price of 264 euros following the third-quarter results. While the laboratory services provider's consolidated sales fell short of expectations, its operating profit aligned with forecasts. The recovery in orders within the BPS division may positively influence the market.
UBS has maintained a 'Buy' rating for Merck KGaA, setting a target price of 190 euros ahead of the Group's Capital Markets Day. Analyst Matthew Weston noted that the new targets align closely with consensus estimates, reflecting the company's strong position in pharmaceuticals and chemicals.
UBS has maintained a "Neutral" rating for Sartorius with a target price of 264 euros following the release of third-quarter figures. While the laboratory services provider's consolidated sales fell short of consensus estimates, its operating profit met expectations. The recovery in orders within the BPS division may positively influence the market.
UBS has maintained its "Buy" rating for Merck KGaA, setting a target price of 190 euros ahead of the Group's Capital Markets Day. Analyst Matthew Weston noted that the new targets align closely with consensus estimates, which had been previously indicated by the company.
Matthew Weston
People
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
ubs maintains buy rating for merck with target price of 190 euros
12:34 17.10.2024
ubs maintains neutral rating on sartorius vz shares with target price of 264 euros
12:34 17.10.2024
ubs maintains neutral rating for sartorius with target price of 264 euros
12:28 17.10.2024
ubs maintains neutral rating for sartorius with target price of 264 euros
12:28 17.10.2024
ubs maintains buy rating for merck kgaa with target price of 190 euros
12:27 17.10.2024
UBS maintains neutral rating for Sartorius after mixed quarterly results
11:41 17.10.2024
UBS maintains buy rating for Merck KGaA with target price of 190 euros
11:40 17.10.2024
Trending
Subcategory
Corporate News
Industry Trends
Stock Market Updates
Retail and Consumer Goods
Global Financial Events
Finance Mergers & Acquisitions
Global Trade Developments
Central Bank Actions
Industry Mergers & Acquisitions
Banking Regulations
CEO Changes
Startups & Entrepreneurship
Market Analysis and Predictions
Financial Scams and Security
Supply Chain Management
Workplace Trends
Government Economic Policies
AI Innovations
Energy Sector Developments
Cryptocurrency Trends
Countries:
Companies:
The Goldman Sachs Group, Inc.
Bank of America Corporation
Apple Inc.
Barclays PLC
Wells Fargo & Company
Alphabet Inc.
Tesla, Inc.
Citigroup Inc.
Lloyds Banking Group plc
Deutsche Bank RV Global PP
PepsiCo, Inc.
Commerzbank AG
Google Inc.
NatWest Group plc
BNP Paribas SA
Morgan Stanley
UBS Group AG
JPMorgan Chase & Co.
NVIDIA Corporation
Amazon.com, Inc.
Currencies:
United States Dollar
Euro
Chinese Yuan
British Pound Sterling
Swiss Franc
Indian Rupee
Japanese Yen
Indonesian Rupiah
Canadian Dollar
Russian Ruble
South Korean Won
United Arab Emirates Dirham
Offshore Chinese Yuan
Ghanaian Cedi
Hungarian Forint
Albanian Lek
Brazilian Real
Singapore Dollar
Qatari Riyal
Jordanian Dinar
People: